Herr I, Lozanovski V, Houben P, Schemmer P, Büchler MW (2013). Sulforaphane and related mustard oils in focus of cancer prevention and therapy. Wiener Med. Wochenschrift, 163, 80-88.
Herr I, Moldenhauer G (2012). EpCAMxCD3 specific antibody combined with TRAIL-lymphocytes as new therapeutic tool for enhanced anti-tumor responses. OncoImmunology, 1, 741-743.
Zhou W, Lv R, Wang X, Mou Y, Cai X, Herr I (2010). Stapler vs suture closure of pancreatic remnant after distal pancreatectomy: a meta-analysis. Am J Surgery., 200, 529-36.
Herr I, Büchler MW (2010). Dietary constituents of broccoli and other cruciferous vegetables: implications for prevention and therapy of cancer. Cancer Treat Rev., 36, 377-83.
Apel A, Zentgraf H, Büchler MW, Herr I (2009). Autophagy – a double edged sword in oncology. Int J. Cancer, 125, 991-995.
Herr I, Gassler N, Friess H and Büchler MW (2007). Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis, 2, 271-291.
Herr I, Schemmer P and Büchler MW. (2007). On the TRAIL to therapeutic intervention in liver disease. Hepatology, 46, 266-274.
Herr I, Groth A, Schemmer P and Büchler MW (2007). Adult stem cells in progression and therapy of hepatocellular carcinoma. Int. J. Cancer, 121, 1875-1882.
Mattern J, Büchler MW and Herr I (2007). Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy. Cancer Biol. Ther, 6, 1345-54.
Herr I and Pfitzenmaier J (2006). Glucocorticoid use in prostate cancer and other solid tumors: implications for effectiveness of cytotoxic treatment and metastases. Lancet Oncology, 7, 425-426.
Herr I and Büchler MW (2006). New in vivo results support concerns about harmful effects of cortisone drugs in the treatment of breast cancer. Cancer Biol. Ther. 8, 941-942.
Rutz HP and Herr I (2005). Glucocorticoid administration in antiemetic therapy: is it safe? Cancer, 15, 2656-2657.
Herr I and Marme A (2005). Glucocorticoids and progression of breast cancer. Cancer Biol. Ther. 4(12).
Rutz HP and Herr I (2004). Interference of glucocorticoids with apoptosis signaling and host-tumor interactions. Cancer Biol. Ther. 3, e32-e35.
Herr I and Debatin K-M (2001). Cellular stress response and apoptosis in cancer therapy. Blood, 98, 2603-2614.
Debatin K-M, Beltinger C, Boehler, T, Fellenberg, J, Friesen, C, Fulda S, Herr I, Los M, Scheuerpflug C and Sieverts H (1997). Regulation of apoptosis through CD95 (APO-I/Fas) receptor-ligand interaction. Biochem. Soc. T. 25,405-410.
Wilhelm D, van Dam H, Herr I, Baumann B, Herrlich P and Angel P (1995). Both ATF-2 and cJun are phosphorylated by stress-activated protein kinases in response to UV irradiation. Immunobiology 193, 143-148.